<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Durham McKinney | Activity</title>
	<link>https://recash.wpsoul.net/members/eralisa35/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/eralisa35/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Durham McKinney.</description>
	<lastBuildDate>Tue, 19 May 2026 20:03:20 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">807868e1387795d8045fe10e1942d38f</guid>
				<title>Durham McKinney posted an update: Non-alcoholic steatohepatitis (NASH) is the most common [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/57760/</link>
				<pubDate>Thu, 12 Dec 2024 08:10:24 +0000</pubDate>

									<content:encoded><![CDATA[<p>Non-alcoholic steatohepatitis (NASH) is the most common chronic liver disease worldwide, and the fastest growing indication for liver transplantation in the United States. NASH is now the leading etiology for liver transplantation in women, the second leading indication for men, and the most common cause amongst recipients aged 65 years and older.&hellip;<span class="activity-read-more" id="activity-read-more-57760"><a href="https://recash.wpsoul.net/activity/p/57760/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c760dfd0f473b047c8fe5be11a01d56e</guid>
				<title>Durham McKinney posted an update: This study aimed to compare the efficacy and safety of [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/56237/</link>
				<pubDate>Wed, 11 Dec 2024 23:24:47 +0000</pubDate>

									<content:encoded><![CDATA[<p>This study aimed to compare the efficacy and safety of ultrasound-guided percutaneous microwave ablation (MWA) for hepatocellular carcinoma (HCC) adjacent to large vessels with those far from large vessels.</p>
<p> The clinical data of patients who underwent ultrasound-guided percutaneous MWA for HCC were retrospectively analyzed between January&hellip;<span class="activity-read-more" id="activity-read-more-56237"><a href="https://recash.wpsoul.net/activity/p/56237/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">36bc2cab5f8f2023d72e37735e76e5c3</guid>
				<title>Durham McKinney became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/56021/</link>
				<pubDate>Wed, 11 Dec 2024 23:02:01 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>